Atul R Khare, PhD, MBA, is VP, Scientific Affairs, Unicycive Therapeutics, Inc., a biotechnology company which is developing two drugs for kidney disease. Dr. Khare has over three decades of experience in the management, commercialization, sales & marketing of drug and medical device R&D technologies. He has had a critical role in the development and implementation of strategies for commercialization and launch of multiple nanotechnology-based products. In addition, he has several years of experience in food R&D technologies. He has held positions at Baxter Healthcare Corporation and other pharmaceutical companies in the Chicago area.
Dr. Khare is a visiting instructor in the Molecular Engineering Department at University of Chicago and teaches a class on commercialization of molecular engineering-based innovations and technologies. He was the course director for a one-day short course titled, “Commercializing Innovation in Food Products,” through the Institute of Food Technologists (IFT) for three years. Dr. Khare received his Ph.D., in Chemical Engineering from Purdue University and an MBA from the University of Chicago Booth School of Business and has authored or co-authored over 50 peer reviewed journal articles, proceeding papers and abstracts, and has 5 patents.